Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Toshihide Nishimura"'
Autor:
Yasufumi Kato, Haruhiko Nakamura, Hiromasa Tojo, Masaharu Nomura, Toshitaka Nagao, Takeshi Kawamura, Tatsuhiko Kodama, Tatsuo Ohira, Norihiko Ikeda, Thomas Fehniger, György Marko‐Varga, Toshihide Nishimura, Harubumi Kato
Publikováno v:
Clinical and Translational Medicine, Vol 4, Iss 1, Pp n/a-n/a (2015)
Abstract BackgroundIn the new pathologic classification of lung adenocarcinoma proposed by IASLC/ATS/ERS in 2011, lepidic type adenocarcinomas are constituted by three subtypes; adenocarcinoma in situ (AIS), minimally invasive adenocarcinoma (MIA) an
Externí odkaz:
https://doaj.org/article/fd3f4d4ef05047f58a1fd3f890bbdf96
Autor:
Toshihide Nishimura, Akos Vegvari, Haruhiko Nakamura, Kiyonaga Fujii, Hiroki Sakai, Saeko Naruki, Naoki Furuya, Hisashi Saji
Publikováno v:
Frontiers in Oncology; 2024, p1-15, 15p
Autor:
Toshihide, Nishimura, Tatsuyuki, Takadate, Shimpei, Maeda, Takashi, Suzuki, Takashi, Minowa, Tetsuya, Fukuda, Yasuhiko, Bando, Michiaki, Unno
Publikováno v:
Scientific Reports. 12
Pancreatic ductal adenocarcinoma (PDAC) is a multifactorial disease, the molecular profile of which remains unclear. This study aimed at unveiling the disease-related protein networks associated with different outcomes of resectable, node-positive PD
Autor:
Tomoyuki Miyazawa, Motohiro Chosokabe, Kiyonaga Fujii, Hiroki Sakai, Hisashi Saji, Haruhiko Nakamura, Kanji Otsubo, Toshihide Nishimura, Koji Kojima, Naoki Furuya, Junki Koike, Hideki Marushima, Hiroyuki Kimura
Publikováno v:
Mol Clin Oncol
Minichromosome maintenance (MCM) protein deregulation is associated with tumor formation, progression and malignant transformation. MCM2 is frequently expressed during premalignant lung cell proliferation and is a sensitive marker for the early detec
Autor:
Masayuki Takagi, Kien Thiam Tan, Saeko Naruki, Shu-Jen Chen, Harubumi Kato, Hisashi Saji, Kiyonaga Fujii, Hirotaka Koizumi, Toshihide Nishimura, Haruhiko Nakamura, De-Wei Zhuo, Yasufumi Kato, Naoki Furuya
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-13 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-13 (2020)
The tumourigenesis of early lung adenocarcinomas, including adenocarcinoma in situ (AIS), minimally invasive adenocarcinoma (MIA), and lepidic predominant invasive adenocarcinoma (LPA), remains unclear. This study aimed to capture disease-related mol
Publikováno v:
Advances in experimental medicine and biology. 926
Molecular therapies targeting lung cancers with mutated epidermal growth factor receptor (EGFR) by EGFR-tyrosin kinase inhibitors (EGFR-TKIs), gefitinib and erlotinib, changed the treatment system of lung cancer. It was revealed that drug efficacy di
Autor:
Sayaka Mikami, Takeshi Kawamura, Hiroko Hamasaki, Harubumi Kato, Toshihide Nishimura, Kiyonaga Fujii, Hiromasa Tojo, Yasuhiko Bando, Masaharu Nomura
Publikováno v:
Journal of Proteomics. 73:1089-1099
We used formalin-fixed paraffin-embedded (FFPE) materials for biomarker discovery in cases of lung cancer using proteomic analysis. We conducted a retrospective global proteomic study in order to characterize protein expression reflecting clinical st
Autor:
Kiyonaga Fujii, Tetsuya Okano, Yuichiro Ohe, Setsuo Hirohashi, Harbumi Kato, Yoshihiro Matsuno, Koji Tsuta, Tadashi Kondo, Toshimi Takano, Shoji Kudoh, Akihiko Gemma, Toshihide Nishimura
Publikováno v:
Clinical Cancer Research. 13:799-805
Purpose: We aimed to identify candidate proteins for tumor markers to predict the response to gefitinib treatment. Experimental Design: We did two-dimensional difference gel electrophoresis to create the protein expression profile of lung adenocarcin
Autor:
Tatsuo Ohira, Hiromasa Tojo, Yasufumi Kato, Tatsuhiko Kodama, H. Nakamura, Norihiko Ikeda, Toshihide Nishimura, Kinya Furukawa, Takeshi Kawamura, György Marko-Varga
Publikováno v:
European Journal of Surgical Oncology (EJSO). 42:S171
Autor:
Kiyonaga Fujii, Harubumi Kato, Hiroko Hamasaki, Toshihide Nishimura, Hiromasa Tojo, Tetsuya Fukuda, Masaharu Nomura, Yasuhiko Bando, Sayaka Mikami
Publikováno v:
Journal of proteomics. 73(6)
A preceding paper suggested 81 candidates of stage-specifically expressed proteins for either stage IA or IIIA by global shotgun proteomics and spectral counting. Six proteins, a subset of these proteins, were chosen for a further verification study